or
forgot password

    • cancer clinical trials in birmingham, AL

    • Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Breast Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors
    Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Leukemia, Myelodysplastic Syndromes
    Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Lymphedema, Perioperative/Postoperative Complications, Vulvar Cancer
    S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Lung Cancer
    Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Metastatic Cancer
    Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma, Mixed, Gliosarcoma
    Neonatal CMV-Ganciclovir Follow-up Study
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Cytomegalovirus Infections
    Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Sarcoma
    S9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Breast Cancer, Colorectal Cancer, Lung Cancer, Pancreatic Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Veterans Affairs Medical Center - Birmingham
    Birmingham, Alabama 35233
    Lung Cancer
    A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Colorectal Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms
    A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Carcinoma, Non-small-cell Lung
    Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Myelodysplastic Syndromes
    For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Neoplasm Metastasis, Colorectal Neoplasms
    Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Breast Neoplasms
    A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis
    Children's Hospital of Alabama
    Birmingham, Alabama 35233
    Papilloma, Recurrent Respiratory Papillomatosis
    Safety Study of Fondaparinux Sodium to Prevent Venous Thromboembolic Events (APOLLO)
    Princeton Baptist Medical Center
    Birmingham, Alabama 35211-1399
    Venous Thrombosis, Surgery, Deep Vein Thrombosis, Pulmonary Embolism, Venous Thromboembolism, Abdominal Surgery
    Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Glioma, Brain Neoplasm
    Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer
    Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Cervical Cancer
    Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Lung Cancer
    Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Multiple Myeloma and Plasma Cell Neoplasm
    Brachytherapy in Treating Patients With Recurrent Malignant Glioma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Lymphoma
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Head and Neck Cancer
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Carcinoma of Unknown Primary
    Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
    National Lung Screening Trial (NLST) Screening
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Lung Cancer
    D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients
    Cooper Green Hospital, Jefferson Clinic

    Trial Locations
    Cooper Green Hospital, Jefferson Clinic
    University of Alabama Palliative Care Institute
    Fatigue, Neoplasms
    HORIZON-PFT: Pivotal Fracture Trial
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Osteoporosis
    Phase II Trial of Allovectin-7® for Head and Neck Cancer
    University of Alabama, Birmingham
    Birmingham, Alabama 35233
    Head and Neck Cancer, Squamous Cell Carcinoma of the Oral Cavity or Oropharynx, Head and Neck Neoplasms, Carcinoma of the Head and Neck
    A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Breast Neoplasms
    A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies
    University of Alabama, Birmingham
    Birmingham, Alabama 35233
    Hodgkin Disease, Lymphoma, Large-Cell, Sarcoma, Kaposi, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell
    Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
    U of Alambama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Non-Small Cell Lung Cancer
    Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma
    Cooper Green Hospital / Jefferson Clinic P.C.
    Birmingham, Alabama 35233
    Colorectal Carcinoma
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
    Veterans Affairs Medical Center - Birmingham
    Birmingham, Alabama 35233
    Malignant Mesothelioma
    Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Neurofibromatosis Type 1, Precancerous Condition
    S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Cervical Cancer
    Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer
    Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Esophageal Neoplasms, Stomach Neoplasms, Adenocarcinoma
    A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Rheumatoid Arthritis
    Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Leukemia
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    Alabama Hematology/Oncology
    Birmingham, Alabama 35243
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Treatment With SU11248 in Patients With Neuroendocrine Tumors
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Neuroendocrine Tumors
    T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients
    University of Alabama
    Birmingham, Alabama
    Hepatocellular Carcinoma
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Lung Cancer
    Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Head and Neck Cancer, Oral Complications of Radiation Therapy, Radiation Toxicity
    S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Cervical Cancer
    Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Lymphoma
    ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Prostate Cancer
    BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Lymphoma
    Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Sarcoma
    Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Lung Cancer
    Alanosine in Treating Patients With Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Lung Cancer, Malignant Mesothelioma, Pancreatic Cancer, Sarcoma